NCT02904096 - Radiesse® Safety Study For the Treatment of Hands | Biotech Hunter

Enrollment

256

Participants

Timeline

Start Date

June 10, 2016

Primary Completion Date

January 9, 2019

Study Completion Date

January 9, 2019

Conditions

Volume Loss in the Dorsum of the Hand

Interventions

DEVICE

Radiesse injectable implant and 2% lidocaine HCL

Radiesse injectable implant injected in small boluses (0.2-0.5cc/bolus). No more than 0.5cc per bolus. No more than 3 cc (2 syringes) will be injected per hand.

Trial Locations (9)

Unknown

Merz Investigative Site #0010393, Sacramento

Merz Investigative Site #0010321, San Diego

Merz Investigative Site #0010358, Vista

Merz Investigative Site #0010099, West Hollywood

Merz Investigative Site #0010405, New York

Merz Investigative Site #0010406, New York

Merz Investigative Site #0010322, Austin

Merz Investigative Site #0010125, Plano

Merz Investigative Site #0010392, Spokane

All Listed Sponsors

lead

Merz North America, Inc.

INDUSTRY